Daniel Comiskey to Proto-Oncogene Proteins c-mdm2
This is a "connection" page, showing publications Daniel Comiskey has written about Proto-Oncogene Proteins c-mdm2.
Connection Strength
1.356
-
Comiskey DF, Montes M, Khurshid S, Singh RK, Chandler DS. SRSF2 Regulation of MDM2 Reveals Splicing as a Therapeutic Vulnerability of the p53 Pathway. Mol Cancer Res. 2020 02; 18(2):194-203.
Score: 0.656
-
Comiskey DF, Jacob AG, Singh RK, Tapia-Santos AS, Chandler DS. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage. Nucleic Acids Res. 2015 Apr 30; 43(8):4202-18.
Score: 0.478
-
Jacob AG, Singh RK, Comiskey DF, Rouhier MF, Mohammad F, Bebee TW, Chandler DS. Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways. PLoS One. 2014; 9(8):e104444.
Score: 0.114
-
Jacob AG, O'Brien D, Singh RK, Comiskey DF, Littleton RM, Mohammad F, Gladman JT, Widmann MC, Jeyaraj SC, Bolinger C, Anderson JR, Barkauskas DA, Boris-Lawrie K, Chandler DS. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma. Neoplasia. 2013 Sep; 15(9):1049-63.
Score: 0.107